NASDAQ:SLNO

Soleno Therapeutics News Headlines

$1.10
-0.08 (-6.78 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.10
Now: $1.10
$1.18
50-Day Range
$1.12
MA: $1.55
$2.69
52-Week Range
$1.10
Now: $1.10
$4.39
Volume925,798 shs
Average Volume1.68 million shs
Market Capitalization$87.70 million
P/E RatioN/A
Dividend YieldN/A
Beta0.71

Headlines

Soleno Therapeutics (NASDAQ SLNO) News Headlines Today

SourceHeadline
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Expected to Announce Earnings of -$0.04 Per ShareSoleno Therapeutics, Inc. (NASDAQ:SLNO) Expected to Announce Earnings of -$0.04 Per Share
americanbankingnews.com - April 18 at 6:18 PM
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Sees Significant Increase in Short InterestSoleno Therapeutics, Inc. (NASDAQ:SLNO) Sees Significant Increase in Short Interest
americanbankingnews.com - April 18 at 4:44 AM
Soleno Therapeutics Participates in Prader-Willi Syndrome (PWS) DCCR Town HallSoleno Therapeutics Participates in Prader-Willi Syndrome (PWS) DCCR Town Hall
finance.yahoo.com - April 15 at 12:21 AM
Soleno Therapeutics (NASDAQ:SLNO) Stock Price Passes Below Fifty Day Moving Average of $1.90Soleno Therapeutics (NASDAQ:SLNO) Stock Price Passes Below Fifty Day Moving Average of $1.90
americanbankingnews.com - April 9 at 3:42 AM
Financial Comparison: Helius Medical Technologies (NASDAQ:HSDT) vs. Soleno Therapeutics (NASDAQ:SLNO)Financial Comparison: Helius Medical Technologies (NASDAQ:HSDT) vs. Soleno Therapeutics (NASDAQ:SLNO)
americanbankingnews.com - March 31 at 8:44 AM
Soleno Therapeutics (SLNO) Enters Oversold TerritorySoleno Therapeutics (SLNO) Enters Oversold Territory
finance.yahoo.com - March 30 at 9:01 AM
Heres Why Were Watching Soleno Therapeutics (NASDAQ:SLNO) Cash Burn SituationHere's Why We're Watching Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation
finance.yahoo.com - March 29 at 5:55 PM
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Short Interest Up 125.5% in MarchSoleno Therapeutics, Inc. (NASDAQ:SLNO) Short Interest Up 125.5% in March
americanbankingnews.com - March 29 at 10:55 AM
SLNO Jul 2021 4.000 callSLNO Jul 2021 4.000 call
au.finance.yahoo.com - March 13 at 9:23 AM
Soleno to Participate in the 31st Annual Oppenheimer Healthcare ConferenceSoleno to Participate in the 31st Annual Oppenheimer Healthcare Conference
finance.yahoo.com - March 9 at 5:38 PM
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Contact the FirmBronstein, Gewirtz & Grossman, LLC Announces Investigation of Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Contact the Firm
finance.yahoo.com - March 9 at 12:38 PM
Soleno Therapeutics (SLNO) Is in Oversold Territory: Whats Next?Soleno Therapeutics (SLNO) Is in Oversold Territory: What's Next?
msn.com - March 9 at 7:38 AM
Why Soleno Therapeutics Is Trading Lower TodayWhy Soleno Therapeutics Is Trading Lower Today
msn.com - March 8 at 12:51 PM
Soleno Shares Are Trading Lower After FDA Demands Additional Study For DCCR Program In Prader-Willi SyndromeSoleno Shares Are Trading Lower After FDA Demands Additional Study For DCCR Program In Prader-Willi Syndrome
finance.yahoo.com - March 8 at 12:51 PM
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial ResultsSoleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
finance.yahoo.com - March 3 at 6:39 PM
Soleno Therapeutics, Vanderbilt University In Research Pact For K(ATP) Channel ActivatorsSoleno Therapeutics, Vanderbilt University In Research Pact For K(ATP) Channel Activators
finance.yahoo.com - February 23 at 1:05 PM
Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi SyndromeSoleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome
finance.yahoo.com - February 5 at 10:07 AM
SLNO Feb 2021 4.000 callSLNO Feb 2021 4.000 call
au.finance.yahoo.com - February 2 at 6:25 PM
SLNO Feb 2021 3.000 callSLNO Feb 2021 3.000 call
au.finance.yahoo.com - January 28 at 6:08 PM
Soleno Therapeutics to Host Key Opinion Leader Meeting on DCCR for the Treatment of Prader-Willi SyndromeSoleno Therapeutics to Host Key Opinion Leader Meeting on DCCR for the Treatment of Prader-Willi Syndrome
finance.yahoo.com - January 28 at 1:07 PM
SLNO Feb 2021 1.000 callSLNO Feb 2021 1.000 call
au.finance.yahoo.com - January 27 at 10:56 PM
Soleno Therapeutics: Could Be Big Fish In The Small PondSoleno Therapeutics: Could Be Big Fish In The Small Pond
seekingalpha.com - January 10 at 12:03 PM
Soleno Therapeutics, Inc. (SLNO)Soleno Therapeutics, Inc. (SLNO)
finance.yahoo.com - January 5 at 11:09 PM
Soleno Therapeutics to Present at the H.C. Wainwright Virtual BioConnect 2021 ConferenceSoleno Therapeutics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
finance.yahoo.com - January 4 at 9:36 AM
Is SLNO A Good Stock To Buy Now?Is SLNO A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 9:09 AM
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi SyndromeSoleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
finance.yahoo.com - December 11 at 10:10 AM
Soleno Therapeutics EPS misses by $0.02Soleno Therapeutics EPS misses by $0.02
seekingalpha.com - November 10 at 7:03 PM
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial ResultsSoleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 10 at 7:02 PM
Soleno Therapeutics presents body composition results from mid-stage DCCR study in prader-willi syndromeSoleno Therapeutics presents body composition results from mid-stage DCCR study in prader-willi syndrome
seekingalpha.com - November 4 at 7:58 AM
Soleno Therapeutics Announces Presentation of Body Composition Results from DESTINY PWS, a Phase III Trial of DCCR in Prader-Willi SyndromeSoleno Therapeutics Announces Presentation of Body Composition Results from DESTINY PWS, a Phase III Trial of DCCR in Prader-Willi Syndrome
finance.yahoo.com - November 3 at 7:53 PM
Soleno Therapeutics Announces Late-Breaking Oral Presentation with Body Composition Results from Phase III DESTINY PWS Trial of DCCR in Prader-Willi Syndrome at ObesityWeek® 2020 MeetingSoleno Therapeutics Announces Late-Breaking Oral Presentation with Body Composition Results from Phase III DESTINY PWS Trial of DCCR in Prader-Willi Syndrome at ObesityWeek® 2020 Meeting
finance.yahoo.com - October 29 at 1:02 PM
Soleno Therapeutics Shares March Higher, Can It Continue?Soleno Therapeutics' Shares March Higher, Can It Continue?
nasdaq.com - October 2 at 12:48 PM
Updated data from Solenos DCCR late-stage study shows positive outcome in obesity disorderUpdated data from Soleno's DCCR late-stage study shows positive outcome in obesity disorder
seekingalpha.com - September 30 at 5:32 PM
Soleno Therapeutics to Participate in Fireside Chat at the Oppenheimer Fall Healthcare Life Sciences & MedTech SummitSoleno Therapeutics to Participate in Fireside Chat at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
finance.yahoo.com - September 15 at 12:36 PM
Soleno (SLNO) in Focus: Stock Moves 6.3% HigherSoleno (SLNO) in Focus: Stock Moves 6.3% Higher
finance.yahoo.com - August 20 at 1:54 PM
A Second Look At Soleno TherapeuticsA Second Look At Soleno Therapeutics
seekingalpha.com - August 17 at 8:13 PM
SLNO Oct 2020 1.000 callSLNO Oct 2020 1.000 call
ca.finance.yahoo.com - August 17 at 8:27 AM
SLNO Jan 2021 5.000 callSLNO Jan 2021 5.000 call
ca.finance.yahoo.com - August 17 at 8:27 AM
Soleno Therapeutics EPS beats by $0.04Soleno Therapeutics EPS beats by $0.04
seekingalpha.com - August 10 at 5:11 PM
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial ResultsSoleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 10 at 5:11 PM
Soleno (SLNO) to report Q2 Earnings: Whats in the Cards?Soleno (SLNO) to report Q2 Earnings: What's in the Cards?
www.nasdaq.com - July 27 at 1:21 PM
Soleno (SLNO) to report Q2 Earnings: What's in the Cards?Soleno (SLNO) to report Q2 Earnings: What's in the Cards?
finance.yahoo.com - July 27 at 1:21 PM
Soleno Therapeutics (SLNO) StockSoleno Therapeutics (SLNO) Stock
markets.businessinsider.com - July 27 at 12:17 AM
ORGS, SLNO, CDTX, BLPH, ARCT added to IndexesORGS, SLNO, CDTX, BLPH, ARCT added to Indexes
seekingalpha.com - June 29 at 9:48 AM
Soleno Therapeutics Added to Russell 3000® IndexSoleno Therapeutics Added to Russell 3000® Index
finance.yahoo.com - June 29 at 9:48 AM
Trade Alert: Jack Schuler At Soleno Therapeutics, Inc. (NASDAQ:SLNO), Has Just Spent US$8.5m Buying 83% More SharesTrade Alert: Jack Schuler At Soleno Therapeutics, Inc. (NASDAQ:SLNO), Has Just Spent US$8.5m Buying 83% More Shares
finance.yahoo.com - June 29 at 9:48 AM
Have Insiders Been Buying Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares?Have Insiders Been Buying Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares?
finance.yahoo.com - June 29 at 9:48 AM
Soleno Therapeutics Announces Closing of $57.5 Million Public Offering of Common Stock, Including the Full Exercise of Underwriters’ Option to Purchase Additional SharesSoleno Therapeutics Announces Closing of $57.5 Million Public Offering of Common Stock, Including the Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 26 at 6:37 PM
Translate Bio (TBIO) in Focus: Stock Moves 11.7% HigherTranslate Bio (TBIO) in Focus: Stock Moves 11.7% Higher
finance.yahoo.com - June 26 at 12:28 AM
Hedge Funds Have Never Been This Bullish On Soleno Therapeutics, Inc. (SLNO)Hedge Funds Have Never Been This Bullish On Soleno Therapeutics, Inc. (SLNO)
finance.yahoo.com - June 25 at 7:28 PM
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.